← Back to Search

Blood Flow Restricted Exercise + Transspinal Stimulation for Quadriplegia (SCIMS Main Trial)

N/A
Recruiting
Led By Ashraf Gorgey, MPT, PhD, FACSM, FACRM
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Response of muscle contraction of wrist extensors bilaterally to neuromuscular electrical stimulation
Participants must have a companion that will be able to help him/her throughout the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 20 weeks
Awards & highlights

SCIMS Main Trial Summary

This trial is testing whether a home-based exercise program supported by telehealth, combining Blood Flow Restricted Exercise and Transspinal Stimulation, will improve motor and functional abilities more than the same program with sham Transspinal Stimulation.

Who is the study for?
This trial is for individuals with chronic, incomplete tetraplegia who can safely engage in the study exercises and have a companion to assist them. They must be able to use telehealth technology, be over one year post spinal cord injury (SCI), and not have severe neurological conditions or implanted devices that could interfere with the interventions.Check my eligibility
What is being tested?
The study tests if combining Blood Flow Restricted Exercise (BES) with Transspinal Stimulation (TS) at home via telehealth improves motor functions more than BES combined with sham TS in people with incomplete tetraplegia.See study design
What are the potential side effects?
Potential side effects are not explicitly listed but may include discomfort from exercise or stimulation, skin irritation from equipment, muscle soreness, and fatigue. Safety measures will monitor for adverse reactions.

SCIMS Main Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My wrist muscles respond to electrical stimulation therapy.
Select...
I have someone who can assist me during the study.
Select...
My spinal cord injury is above C8 and happened over a year ago.
Select...
My wrist muscles respond to electrical stimulation on both sides.

SCIMS Main Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 20 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in EMG activation without TS
Change in electrical activity activation with TS
Change in hand functional activities
+3 more
Secondary outcome measures
Change in heart rate variability
Change in ventilatory muscle strength
Change in vital capacity
+1 more

SCIMS Main Trial Design

2Treatment groups
Experimental Treatment
Group I: BES+sham TSExperimental Treatment1 Intervention
Blood Flow Restriction Enhanced Neuromuscular Electrical Stimulation (BES) sham treatment plus transspinal stimulation (TS) plus repetitive practice of task-specific activities, also known as massed practice (MP)
Group II: BES+TSExperimental Treatment1 Intervention
Blood Flow Restriction Enhanced Neuromuscular Electrical Stimulation (BES) treatment plus transspinal stimulation (TS) plus repetitive practice of task-specific activities, also known as massed practice (MP)

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
699 Previous Clinical Trials
22,885,001 Total Patients Enrolled
Administration for Community LivingUNKNOWN
Department of Health and Human Services Administration For Community LivingUNKNOWN

Media Library

Blood Flow Restricted Exercise Clinical Trial Eligibility Overview. Trial Name: NCT05423600 — N/A
Quadriplegia/Quadriparesis Research Study Groups: BES+sham TS, BES+TS
Quadriplegia/Quadriparesis Clinical Trial 2023: Blood Flow Restricted Exercise Highlights & Side Effects. Trial Name: NCT05423600 — N/A
Blood Flow Restricted Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05423600 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor accepting participants aged 55 and over?

"This experiment is open to all individuals who are 18 years of age or above and below the age of 70."

Answered by AI

Is it possible for new participants to enroll in this research trial?

"The information posted on clinicaltrials.gov confirms that enrollment for this medical study is still open; the trial was initially uploaded to the website 15th June 2022 and was last updated 24th June 2022."

Answered by AI

Are there any specific demographics that are favored to enroll in this study?

"This medical trial is seeking 44 participants between the ages of 18 and 70 who have suffered from quadriplegia. To be considered, individuals must also meet the following requirements: they should possess a companion that can help them throughout their study period; it has been more than one year since their spinal cord injury (SCI); neurologic level of C8 or higher; American Spinal Injury Association Impairment Scale scores B-D, signifying an incomplete SCI; visible muscle contraction response to NMES wrist extensors on both sides when exposed to neuromuscular electrical stimulation; clearance from a doctor confirming participant's ability"

Answered by AI

What is the maximum cohort size for this clinical research?

"Affirmative. The clinical trial is actively recruiting according to the data hosted on clinicaltrials.gov, which was initially posted on June 15th 2022 and subsequently updated a week ago. This medical study seeks 44 participants at 3 distinct research sites."

Answered by AI

What are the key goals of this investigation?

"This medical trial will assess Change in hand functional activities as its primary outcome, with Baseline to 20 weeks being the time frame of interest. Secondary evaluation criteria include Changes in heart rate variability (assessed via Tilt table test), Changes in capacity to perform functional activities (measured using SCI-FI SF) and finally Change in vital capacity which is determined through Forced vital capacity testing."

Answered by AI
~25 spots leftby Sep 2026